Low Dose Olanzapine to the Prophylaxis of Nausea and Vomiting Induced by Chemotherapy in Children and Adolescents
Condition: Chemotherapy-induced Nausea and Vomiting Interventions: Drug: Ondansetron; Drug: Dexamethasone; Drug: Aprepitant; Drug: Olanzapine Sponsor: Federal Research Institute of Pediatric Hematology, Oncology and Immunology Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Allergy & Immunology | Cancer & Oncology | Chemotherapy | Children | Dexamethasone | Hematology | Pediatrics | Research | Zofran | Zyprexa